CHASM-CS Registry
Registry for the Cardiac Sarcoidosis Multi-Center Cohort
Objective
1. To follow clinical outcomes in patients with clinically manifest CS.
2. To follow clinical outcomes in patients with clinically silent CS in comparison to controls i.e. patients with extra-cardiac sarcoidosis with no evidence of CS.
-
Inclusion
Clinically Manifest CS:
-
< 60 years old
-
Unexplained, new onset significant conduction disease (2nd or 3rd degree AV block)
-
Idiopathic sustained monomorphic VT (in a structurally normal heart
Clinically Silent CS:
-
Diagnosed (by biopsy) pulmonary/systemic sarcoidosis and abnormal:
-
ECG: LBBB, RBBB, path. Q waves in 2+ leads
-
Holter: VT (sustained or nonsustained)
-
Echo: RWMA/aneurysm, EF < 50%
-
-
Exclusion
None
Additional Info
Ethics ID: REB15-0329
ClinicalTrials.gov ID: NCT01477359
Sponsor: Ottawa Heart Institute Research Corporation
PI: Dr. Russell Quinn
Phone: 403 210 6152
Admin: Jennifer McKeage
Phone: 403 210-6047
E-mail: jmckeage@ucalgary.ca
Updated Sept 19, 2023